Portage Biotech Reports Business and Strategic Update

January 4, 2024

https://www.globenewswire.com/news-release/2024/01/04/2803981/0/en/Portage-Biotech-Reports-Business-and-Strategic-Update.html

WESTPORT, Conn., Jan. 04, 2024 (GLOBE NEWSWIRE) — Portage Biotech Inc. (NASDAQ:PRTG), a clinical-stage immuno-oncology company advancing novel multi-targeted therapies for use as monotherapy and in combination, today announced the outcome from the company’s comprehensive review of its pipeline in the context of the current capital raising market conditions.

Read more at globenewswire.com

Related news for (PRTG)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.